HSPOF 10-K & 10-Q changes, risk factors and insider trading
Horizon Space Acquisition I Corp. (also HSPUF, HSPWF) · OTC · Blank Checks · CIK 1946021 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
As a smaller reporting company, we are not required to include risk factors in this Annual Report.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
New heading “Termination of the Business Combination Agreement”
New heading “October 2025 Shareholder Meeting”
New heading “Amendment to the Underwriting Agreement”
New heading “Trading on OTC Market”
Removed heading “Proposed Transactions with Squirrel”
Largest changes
“On December 3, 2025, the Company notified the Nasdaq Stock Market LLC (“Nasdaq”) of the Company’s decision to voluntarily delist its ordinary shares, units, warrants, and rights from the Nasdaq Capital Market. The Company’s ordinary shares, units, warrants, and rights were suspended from trading on the Nasdaq Capital Market prior to market open on December 12, 2025, and commenced trading on the over-the-counter markets operated by OTC Markets Group Inc. (the “OTC”) on the same day. The Company filed the Form 25 with the SEC on December 12, 2025. …”see in full comparison
“Pursuant to the Business Combination Agreement, among other things, (a) HoldCo will merge with and into PubCo in accordance with the Companies Act (Revised) of the Cayman Islands (the “Cayman Companies Act”), whereupon the separate existence of HoldCo will cease, and PubCo will be the surviving company (the “Reorganization”), and (b) at least one (1) business day after the closing of the Reorganization (the “Reorganization Closing”), Merger Sub will merge with and into HSPO in accordance with the Cayman Companies Act, whereupon the separate existence of Merger Sub will cease, and HSPO will be …”see in full comparison
Full comparison: every changed paragraph (29)
We are a blank check company formed under the laws of Cayman Island on June 14, 2022, for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. On September 16, 2024, we entered into a Business Combination Agreement (defined below) with Group Companies (defined below) and contemplating the Transactions (defined below) thereunder.
We expect to continue to incur significant costs in the pursuit of consummation of thea Transactions.business combination. We cannot assure you that our plans to raise capital or to complete thea Transactionsbusiness combination will be successful.
Termination of the Business Combination Agreement
Proposed Transactions with Squirrel
Effective October 3, 2025, the Company and HoldCo entered into a termination agreement (the “Termination Agreement”), which provides for the termination of the Business Combination Agreement. The termination was by mutual agreement of the Company and HoldCo pursuant to Section 10.1(a) of the Business Combination Agreement and no termination fee or other payment is due to either party from the other as a result of the termination. The effect of the termination of the Business Combination Agreement is as set forth in Section 10.2 of the Business Combination Agreement.
HoldCo, through Shenzhen Squirrel Enlivened Media Group Co., Ltd, a limited liability company established under the laws of China (“Shenzhen Squirrel”), and HoldCo’s other subsidiaries, including Squirrel Enlivened (Hong Kong) Technology Limited (“Squirrel HK”), is in the business of brand marketing and strategy consulting.
Pursuant to the Business Combination Agreement, among other things, (a) HoldCo will merge with and into PubCo in accordance with the Companies Act (Revised) of the Cayman Islands (the “Cayman Companies Act”), whereupon the separate existence of HoldCo will cease, and PubCo will be the surviving company (the “Reorganization”), and (b) at least one (1) business day after the closing of the Reorganization (the “Reorganization Closing”), Merger Sub will merge with and into HSPO in accordance with the Cayman Companies Act, whereupon the separate existence of Merger Sub will cease, and HSPO will be the surviving company (the “Merger”). As a result of the Reorganization and the Merger, among other things, (a) all of the issued and outstanding securities of HoldCo immediately prior to the filing of the plan of merger with respect to the Reorganization (the “Plan of Reorganization”) to the Registrar of Companies of the Cayman Islands, or such later time as may be specified in the Plan of Reorganization (the “Reorganization Effective Time”) shall no longer be outstanding and shall automatically be cancelled, in exchange for the right of the holders thereof to receive a certain number of securities of PubCo as described below, and (b) all of the issued and outstanding securities of HSPO immediately prior to the filing of the plan of merger with respect to the Merger (the “Plan of Merger”) to the Registrar of Companies of the Cayman Islands, or such later time as may be specified in the Plan of Merger (the “Merger Effective Time”) shall no longer be outstanding and shall automatically be cancelled, in exchange for the right of the holders thereof to receive substantially equivalent securities of PubCo, in each case, upon the terms and subject to the conditions set forth in the Business Combination Agreement and in accordance with the provisions of the Cayman Companies Act and other applicable laws. The Reorganization, the Merger, and each of the other transactions contemplated by the Business Combination Agreement or any of the other relevant Transaction Documents (as defined in the Business Combination Agreement) are collectively referred to as “Transactions.”
Pursuant to the Business Combination Agreement, each ordinary share of HoldCo, par value $0.0001 per share (the “HoldCo Ordinary Shares”) issued and outstanding immediately prior to the Reorganization Effective Time, subject to certain exceptions, shall be cancelled and automatically converted into the right to receive, without interest, such number of the newly issued shares of the ordinary shares of PubCo, par value $0.0001 per share (the “PubCo Ordinary Shares”) that is equal to a ratio, being equal to a fraction: (A) the numerator of which is $200,000,000 divided by $10.00 per share, and (B) the denominator of which is the total number of HoldCo Ordinary Shares issued and outstanding immediately prior to the Reorganization Effective Time.
October 2025 Shareholder Meeting
On October 27, 2025, we held an extraordinary general meeting in lieu of an annual meeting of shareholders (the “Fourth Shareholder Meeting”), where the shareholders of the Company approved certain proposals, including, among others, the proposals to amend Articles 48.7 and 48.8 of the Company’s amended and restated memorandum and articles of association to provide that the Company must (i) consummate a business combination, or (ii) cease its operations except for the purpose of winding up if it fails to complete such business combination and redeem or repurchase 100% of the Company’s public shares included as part of the public units issued in the Company’s initial public offering, by October 27, 2025, and if the Company does not consummate a business combination by October 27, 2025, it may be extended up to six times, each by a monthly extension, for a total of up to six months to April 27, 2026, without the need for any further approval of the Company’s shareholders. At the 2025 Shareholder Meeting, the shareholders of the Company also approved the proposal to amend Articles 48.2, 48.4, 48.5, and 48.8 of the Company’s amended and restated memorandum and articles of association to eliminate the limitation that the Company may not redeem the Company’s public shares in an amount that would cause the Company’s net tangible assets to be less than US$5,000,001 following such redemptions.
In connection with the 2025 Shareholder Meeting, the Company received redemption requests from its public shareholders to redeem a total of 1,764,505 Ordinary Shares and approximately $22.0 million was released from the Trust Account to pay such redeeming shareholders.
At the Fourth Shareholder Meeting, the shareholders of the Company approved, among other things, that the Trustee must commence liquidation of the Trust Account by December 27, 2025, if further extended by up to six monthly extensions, up to April 27, 2026. Upon the shareholders’ approval, on October 27, 2025, the Company and the Trustee entered into an amendment to the Trust Agreement, pursuant to which no extension fee is required for each monthly extension.
Amendment to the Underwriting Agreement
On September 29, 2025, the Company entered into an amendment to the underwriting agreement dated as of December 21, 2022 (the “UA Amendment”) with Network 1 Financial Securities, Inc. (“Network 1”), the representative of several underwriters of the IPO.
Pursuant to the UA Amendment, Network 1 agrees to convert the total amount of its deferred underwriting commission in the amount of $2,415,000, or 3.5% of the gross proceeds from the IPO, into 805,000 Ordinary Shares of the post-combination entity at $3.00 per share (the “Deferred Underwriting Shares”) immediately prior to the consummation of the Company’s initial business combination. The Company agrees to register the Deferred Underwriting Shares under the registration statement to be filed by the Company with SEC under the Securities Act of 1933, as amended (the “Securities Act”) in connection with the initial business combination. If the Company fails to register such Deferred Underwriting Shares, Network 1 is entitled to up to two (2) demand registrations and an unlimited number of piggyback registrations with respect to such Deferred Underwriting Shares.
Trading on OTC Market
On December 3, 2025, the Company notified the Nasdaq Stock Market LLC (“Nasdaq”) of the Company’s decision to voluntarily delist its ordinary shares, units, warrants, and rights from the Nasdaq Capital Market. The Company’s ordinary shares, units, warrants, and rights were suspended from trading on the Nasdaq Capital Market prior to market open on December 12, 2025, and commenced trading on the over-the-counter markets operated by OTC Markets Group Inc. (the “OTC”) on the same day. The Company filed the Form 25 with the SEC on December 12, 2025. Following the Nasdaq delisting, the Company’s ordinary shares, rights and warrants were quoted on the OTCQB and its units were quoted on the OTCID under symbols “HSPOF,” “HSPRF,” “HSPWF,” and “HSPUF,” respectively.
In connection with the historical extensions, as of the date hereof, an aggregate of $1,320,000$2,160,000 extension fees had been deposited into the Trust Account, among which $70,000$190,000 was made by the Sponsor and $1,250,000$1,970,000 was made by Shenzhen Squirrel or Squirrel HK, respectively. TheAs of the date of this report, the Company issued a total of 1825 unsecured promissory notes to evidence the payment of the Monthlyextension Extension Fees,fees, including 1two notenotes to the Sponsor (the “Sponsor Extension Notes”) and 1723 notes to Shenzhen Squirrel or Squirrel HK (the “Squirrel Extension Notes,” together with the Sponsor Extension Note, collectively the “Extension Notes”), respectively.
On September 14, 2024, Shenzhen Squirrel notified HSPO that it has elected not to convert the Squirrel Extension Notes into Conversion Units upon the consummation of the Transactions, and since September 2024, all the subsequent Squirrel Extension Notes were issued without such conversion rights, thus Squirrel Extension Notes will become intercompany notes between PubCo and any other Group Companies, as applicable, upon the Merger Closing.
As of the date hereof, HSPO has issued threefive (35) Sponsor Working Capital Notes to the Sponsor on April 12, 2024, October 8, 2024 and February 5, 2025, June 13, 2025 and January 26, 2026, respectively, in connection with the Working Capital Loans in a total amount of $1,000,000$1,800,000 provided by the Sponsor (such three unsecured promissory notes, the “Sponsor Working Capital Notes” and, together with the Extension Notes, collectively, the “Notes”). The proceeds of the Sponsor Notes, which may be drawn down from time to time until the Company consummates its initial business combination, will be used for general working capital purposes.
We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities and those necessary to prepare for the IPO, search for a target andto preparecomplete thea Transactions.business combination. Following the IPO, we have not generated any operating revenues until after completion of our initial business combination. We will generate non-operating income in the form of interest income on cash and cash equivalents after the IPO. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. After the IPO, we incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for expenses associated with the search for target opportunities.
For the year ended December 31, 2025, we had a net income of $203,618 which consisted of interest and dividend income of $779,992 on investments held in Trust Account which was offset by operating cost of $576,374.
For the year ended December 31, 2023, we had a net income of $2,911,033 which consisted of interest and dividend income of $3,471,188 on investments held in Trust Account which was offset by operating cost of $560,155.
We intend to use substantially all of the net proceeds of the IPO, including the funds held in the Trust Account, to acquire a target business or businesses and to pay our expenses relating thereto, including deferred underwriting commissions of $2,415,000 payable to Network 1.thereto. To the extent that our share capital is used in whole or in part as consideration to effect our initial business combination, the remaining proceeds held in the Trust Account as well as any other net proceeds not expended will be used as working capital to finance the operations of the target business. Such working capital funds could be used in a variety of ways including continuing or expanding the target business’ operations, for strategic acquisitions and for marketing, research and development of existing or new products. Such funds could also be used to repay any operating expenses or finders’ fees which we had incurred prior to the completion of our initial business combination if the funds available to us outside of the Trust Account were insufficient to cover such expenses.
Over the next 12 months (assuming a business combination is not consummated prior thereto), we will be using the funds held outside of the Trust Account to consummate the Transactions with Squirrel or if the Transactions is terminated, to complete an alternativea business combination.
As of the date of this report, we have been relied on the loans from the Sponsor or Squirrel in support of our operations, contemplating the Transactions or the Third Shareholder Meeting Related Extensions.operations. We may need to obtain additional financing either to consummate our initial business combination or because we become obligated to redeem a significant number of our public shares upon consummation of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination. Subject to compliance with applicable securities laws, we would only consummate such financing simultaneously with the consummation of our initial business combination. Following our initial business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.
We are obligated to pay the underwriters a deferred underwriting fees equal to 3.5% of the gross proceeds of the IPO. Pursuant to the UA Amendment, Network 1 agrees to convert the total amount of its deferred underwriting commission in the amount of $2,415,000, or 3.5% of the gross proceeds from the IPO, into 805,000 Ordinary Shares of the post-combination entity at $3.00 per share immediately prior to the consummation of the Company’s initial business combination.
We are obligated to pay the underwriters a deferred underwriting fees equal to 3.5% of the gross proceeds of the IPO. Upon completion of the business combination, $2,415,000 will be paid to the underwriters from the funds held in the Trust Account.
In August 2020, the FASB issued a new standard (ASU 2020-06) to reduce the complexity of accounting for convertible debt and other equity-linked instruments. For certain convertible debt instruments with a cash conversion feature, the changes are a trade-off between simplifications in the accounting model (no separation of an “equity” component to impute a market interest rate, and simpler analysis of embedded equity features) and a potentially adverse impact to diluted earnings per share by requiring the use of the if-converted method. The new standard will also impact other financial instruments commonly issued by both public and private companies. For example, the separation model for beneficial conversion features is eliminated simplifying the analysis for issuers of convertible debt and convertible preferred stock. Also, certain specific requirements to achieve equity classification and/or qualify for the derivative scope exception for contracts indexed to an entity’s own equity are removed, enabling more freestanding instruments and embedded features to avoid mark-to-market accounting. The new standard is effective for companies that are SEC filers (except for smaller reporting companies) for fiscal years beginning after December 15, 2021 and interim periods within that year, and two years later for other companies. Companies can early adopt the standard at the start of a fiscal year beginning after December 15, 2020. The standard can either be adopted on a modified retrospective or a full retrospective basis.
What changed in the latest 10-Q
Risk Factors
Not applicable to a smaller reporting company. However, factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in the prospectus for the IPO (File No. 333-268578)(the “IPO Prospectus”) and our annual report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”) as filed with the SEC on April 15, 2026. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in the IPO Prospectus and the Annual Report.
Largest changes
Not applicable to a smaller reporting company. However, factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described insee in full comparisonourthe prospectus for the IPOprospectus(File No. 333-268578)(the “IPO Prospectus”) and our annual report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”) as filed with the SEC on April 15, 2026. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed inourthe IPOprospectusProspectus and the Annual Report.
Full comparison: every changed paragraph (1)
Not applicable to a smaller reporting company. However, factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in ourthe prospectus for the IPO prospectus(File No. 333-268578)(the “IPO Prospectus”) and our annual report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”) as filed with the SEC on April 15, 2026. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in ourthe IPO prospectusProspectus and the Annual Report.
Management's Discussion & Analysis (MD&A)
Largest changes
“On December 3, 2025, the Company notified the Nasdaq of the Company’s decision to voluntarily delist its ordinary shares, units, warrants, and rights from the Nasdaq Capital Market. The Company’s ordinary shares, units, warrants, and rights suspended from trading on the Nasdaq Capital Market prior to market open on December 12, 2025, and commenced trading on the over-the-counter markets operated by OTC Markets Group Inc. (the “OTC”) on the same day.”see in full comparison
“For the six months ended June 30, 2026, we had a net loss of $214,150 which consisted of operating cost of $231,999 which was partially offset by interest and dividend income of $17,849 on investments held in the Trust Account.”see in full comparison
For thesee in full comparisonthreesix months endedMarchJune31,30, 2026, cash used in operating activities was$169,917.$276,718. As ofMarchJune31,30, 2026, we had cash of$25,977$204,176 available for working capital needs. For the six months ended June 30, 2025, cash used in operating activities was $354,556. All remaining cash is held in the Trust Account and is generally unavailable for our use, prior to an initial business combination, and is restricted for use either in a business combination or to redeem the ordinary shares. As ofMarchJune31,30, 2026, none of the amount on deposit in the Trust Account was available to be withdrawn as described above.
“For the six months ended June 30, 2025, we had net income of $147,341 which consisted of interest and dividend income of $454,628 on investments held in the Trust Account which was offset by operating costs of $307,287.”see in full comparison
For the three months endedsee in full comparisonMarchJune31,30, 2026, we had a net loss of$123,564$90,586 which consisted of operating costs of $98,060 which was partially offset by interest and dividend income of$10,375$7,474 on investments held in the TrustAccount which was offset by operating cost of $133,939.Account.
For the three months endedsee in full comparisonMarchJune31,30, 2025, we hadanet income of$71,454$75,887 which consisted of interest and dividend income of$224,752$229,876 on investments held in the Trust Account which was offset by operatingcostcosts of$153,298.$153,989.
Full comparison: every changed paragraph (17)
Commencing on or about January 26, 2023, the holders of the Public Units maycould select to separately trade the Ordinary Shares, Warrants, and Rights included in the Public Units. The Ordinary Shares, Warrants, and Rights are currentlywere traded on the Nasdaq Capital Market under the symbols “HSPO,” “HSPOW,” and “HSPOR”, respectively. Public Units not separated willwould continue to trade on Nasdaq under the symbol “HSPOU.”
On December 3, 2025, the Company notified the Nasdaq of the Company’s decision to voluntarily delist its ordinary shares, units, warrants, and rights from the Nasdaq Capital Market. The Company’s ordinary shares, units, warrants, and rights suspended from trading on the Nasdaq Capital Market prior to market open on December 12, 2025, and commenced trading on the over-the-counter markets operated by OTC Markets Group Inc. (the “OTC”) on the same day.
On JanuaryJuly 26,20, 2026, the Company issued one unsecured promissory note in the principal amount of $300,000$500,000 to the Sponsor (the “Sponsor Working Capital Note”). The proceeds of the Sponsor Working Capital Note, which may be drawn down from time to time until the Company consummates its initial business combination, will be used for general working capital purposes.
The Sponsor Working Capital Note bearbears no interest and areis payable in full upon the earlier to occur of (i) the consummation of the Company’s business combination or (ii) the date of expiry of the term of the Company (the “Maturity Date”). The following shall constitute an event of default: (i) a failure to pay the principal within five business days of the Maturity Date; (ii) the commencement of a voluntary or involuntary bankruptcy action, (iii) the breach of the Company’s obligations thereunder; (iv) any cross defaults; (v) an enforcement proceedings against the Company; and (vi) any unlawfulness and invalidity in connection with the performance of the obligations thereunder, in which case the Sponsor Working Capital Note may be accelerated.
We have neither engaged in any operations nor generated any revenues to date. Our activities from inception through MarchJune 31,30, 2026 involved mainly searching for a suitable target for our initial business combination. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. After the IPO, we incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for expenses associated with the search for target opportunities.
For the three months ended MarchJune 31,30, 2026, we had a net loss of $123,564$90,586 which consisted of operating costs of $98,060 which was partially offset by interest and dividend income of $10,375$7,474 on investments held in the Trust Account which was offset by operating cost of $133,939.Account.
For the three months ended MarchJune 31,30, 2025, we had a net income of $71,454$75,887 which consisted of interest and dividend income of $224,752$229,876 on investments held in the Trust Account which was offset by operating costcosts of $153,298.$153,989.
For the six months ended June 30, 2026, we had a net loss of $214,150 which consisted of operating cost of $231,999 which was partially offset by interest and dividend income of $17,849 on investments held in the Trust Account.
For the six months ended June 30, 2025, we had net income of $147,341 which consisted of interest and dividend income of $454,628 on investments held in the Trust Account which was offset by operating costs of $307,287.
For the threesix months ended MarchJune 31,30, 2026, cash used in operating activities was $169,917.$276,718. As of MarchJune 31,30, 2026, we had cash of $25,977$204,176 available for working capital needs. For the six months ended June 30, 2025, cash used in operating activities was $354,556. All remaining cash is held in the Trust Account and is generally unavailable for our use, prior to an initial business combination, and is restricted for use either in a business combination or to redeem the ordinary shares. As of MarchJune 31,30, 2026, none of the amount on deposit in the Trust Account was available to be withdrawn as described above.
As of MarchJune 31,30, 2026, we had cash of $25,977$204,176 and a working capital deficiencydeficit of $3,764,317.$3,862,377. We have incurred and expect to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a business combination. In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about our ability to continue as a going concern. Our management’s plan in addressing this uncertainty is through the funds loaned from our Sponsor, officers, directors or their affiliates. In addition, if we are unable to complete a business combination by June 12, 2027 (the “Combination Period”), our board of directors would proceed to commence a voluntary liquidation and thereby a formal dissolution of us. There is no assurance that our plans to consummate a business combination will be successful within the Combination Period. As a result, management has determined that such additional conditions also raise substantial doubt about our ability to continue as a going concern. Our financial statement does not include any adjustments that might result from the outcome of this uncertainty.
We have no obligations, assets or liabilities that would be considered off-balance sheet arrangements as of MarchJune 31,30, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
As of MarchJune 31,30, 2026, we do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.
The founder shares, the Ordinary Shares included in the Private Units, and any Ordinary Shares that may be issued upon conversion of working capital loans with outstanding balance of $1,474,003$1,759,003 as of MarchJune 31,30, 2026 (and any underlying securities) will be entitled to registration rights pursuant to a registration rights agreement entered into in connection with the IPO. The holders of these securities are entitled to make up to two demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination. We will bear the expenses incurred in connection with the filing of any such registration statements.
On JanuaryJuly 26,20, 2026, the Company issued the Sponsor Working Capital Note in the principal amount of $300,000$500,000 to the Sponsor. The proceeds of the Sponsor Working Capital Note, which may be drawn down from time to time until the Company consummates its initial business combination, will be used for general working capital purposes. The Sponsor Working Capital Note bears no interest and areis payable in full upon the earlier to occur of (i) the consummation of the Company’s business combination or (ii) the date of expiry of the term of the Company (the “Maturity Date”). The following shall constitute an event of default: (i) a failure to pay the principal within five business days of the Maturity Date; (ii) the commencement of a voluntary or involuntary bankruptcy action, (iii) the breach of the Company’s obligations thereunder; (iv) any cross defaults; (v) an enforcement proceedings against the Company; and (vi) any unlawfulness and invalidity in connection with the performance of the obligations thereunder, in which case the Sponsor Working Capital NotesNote may be accelerated. The payees of the Sponsor Working Capital Note have the right, but not the obligation, to convert the Sponsor Working Capital Note, in whole or in part, respectively, into private units (the “Conversion Units”) of the Company, each consisting of one Ordinary Share, one warrant, and one right to receive one-tenth (1/10) of one Ordinary Share upon the consummation of a business combination. The number of Conversion Units to be received by the payees in connection with such conversion shall be an amount determined by dividing (x) the sum of the outstanding principal amount payable to the payees by (y) $10.00.
At MarchJune 31,30, 2026, assets held in the Trust Account were $1,190,366.$753,670. Substantially all of the assets held in the Trust Account were held in mutual funds. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest and dividend income on investments held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.
At MarchJune 31,30, 2026 and December 31, 2025, the assets held in the Trust Account were substantially held in mutual funds and U.S. Treasury securities, respectively. All of the Company’s investments held in the Trust Account are classified as trading securities.
HSPOF insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding HSPOF (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| D. E. Shaw & Co. | 2026-06-30 | 250,000 | $1.6M | — | Sold out |
| Two Sigma Investments | 2026-06-30 | 207,299 | $1.3M | — | Sold out |
| Leon Cooperman | 2026-06-30 | 1,100 | $242 | — | Sold out |